Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.380
-0.030 (-0.88%)
Oct 8, 2026, 3:04 PM CST
Shenzhen Glory Medical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,115 | 1,077 | 1,448 | 1,193 | 1,276 | 1,790 |
Revenue Growth | -17.09% | -25.61% | 21.40% | -6.49% | -28.74% | -21.04% |
Gross Profit Gross Profit Growth | 133.92 | 130.94 | 253.19 | 155 | 215.55 | 319.9 |
Operating Income Operating Income Growth | -179.7 | -163.9 | 16.27 | -111.34 | -136.1 | 68.11 |
Net Income Net Income Growth | -147.47 | -139.58 | 22.28 | -148.89 | -308.06 | 44.52 |
Earnings Per Share EPS Growth | -0.18 | -0.17 | 0.03 | -0.18 | -0.36 | 0.05 |
EPS Growth | - | - | - | - | - | -73.57% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Services Division Medical Services Division Growth | 204.26 | 186.22 | 410.82 | 322.68 | 266.55 | 752.41 |
Production and Sales of Medical Products Production and Sales of Medical Products Growth | 1,759 | 1,755 | 2,080 | 1,730 | 1,916 | 2,040 |
Health Industry Operations Division Health Industry Operations Division Growth | 75.16 | 79.64 | 79.31 | 75.87 | 64.85 | 56.44 |
Intersegment elimination Intersegment elimination Growth | -923.69 | -943.29 | -1,122 | -935.99 | -971.42 | -1,058 |
Total Total Growth | 1,115 | 1,077 | 1,448 | 1,193 | 1,276 | 1,790 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 718.1 | 763.74 | 944.41 | 818.2 | 920.15 | 1,089 |
Total Debt Total Debt Growth | 41.02 | 40 | 269.14 | 290.6 | 332.06 | 392.2 |
Net Cash (Debt) Net Cash Growth | 677.08 | 723.74 | 675.27 | 527.6 | 588.09 | 696.68 |
Net Cash Growth | -7.84% | 7.18% | 27.99% | -10.29% | -15.59% | -11.19% |
Net Cash Per Share Net Cash Per Share Growth | 0.82 | 0.83 | 0.76 | 0.62 | 0.70 | 0.80 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 122.57 | 140.27 | 120.95 | 17.63 | 96.45 | 242.6 |
Capital Expenditures CapEx Growth | -123.29 | -125.26 | -82.15 | -42.07 | -57.3 | -429.97 |
Free Cash Flow Free Cash Flow Growth | -0.72 | 15 | 38.8 | -24.44 | 39.15 | -187.38 |
Free Cash Flow Growth | - | -61.33% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 12.01% | 12.16% | 17.48% | 12.99% | 16.90% | 17.87% |
Operating Margin | -16.12% | -15.21% | 1.12% | -9.33% | -10.67% | 3.81% |
Pretax Margin | -14.18% | -14.63% | 2.32% | -10.70% | -30.13% | 4.15% |
Profit Margin | -13.23% | -12.96% | 1.54% | -12.48% | -24.15% | 2.49% |
FCF Margin | -0.07% | 1.39% | 2.68% | -2.05% | 3.07% | -10.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.008 | - | 0.008 |
Dividend Per Share Growth | 0% | - | - |
Dividend Yield | 0.24% | - | 0.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 116.64 | - | - | 107.94 |
Forward PE | - | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 |
P/FCF Ratio | - | 205.42 | 66.98 | - | 100.33 | - |
PS Ratio | 2.56 | 2.86 | 1.80 | 2.88 | 3.08 | 2.68 |